This information is for reference purposes only. It was current when produced and may now be outdated. Archive material is no longer maintained, and some links may not work. Persons with disabilities having difficulty accessing this information should contact us at: https://info.ahrq.gov. Let us know the nature of the problem, the Web address of what you want, and your contact information.
Please go to www.ahrq.gov for current information.
Press Release Date: October 30, 2000
The Agency for Healthcare Research and Quality (AHRQ) announces the availability of a summary of an evidence report on the management of acute exacerbations of chronic obstructive pulmonary disease (COPD.)
The report was developed by the Duke University Evidence-based Practice Center under contract to AHRQ. Researchers assessed the evidence currently available on diagnosis, prognosis and management of acute exacerbations of COPD. The report concentrates on the care of patients in outpatient and inpatient settings and shows that the current therapies benefit some patients. The evidence suggests that patients with acute exacerbation of COPD respond differently to certain treatments including corticosteriods and bronchodilators than patients with respiratory distress due to other causes such as asthma.
This report is the basis for a clinical practice guideline developed by the American College of Physicians-American Society of Internal Medicine and the American College of Chest Physicians. It will be published in Chest and Annals of Internal Medicine sometime in the winter of 2001.
The summary is available online at http://www.ahrq.gov/clinic/epcsums/copdsum.htm. Print copies are available from the AHRQ Publications Clearinghouse by writing to P.O. Box 8547, Silver Spring, MD 20907, or by calling (800) 358-9295. Copies of the full report are expected to be available in early 2001.
The Agency's newly redesigned Web site now includes a special section for reporters. Select http://www.ahrq.gov/news/vnewsix.htm for easier access to the latest news and information about AHRQ's research and products.
For more information, contact AHRQ Public Affairs (301) 427-1364.